These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 19086854)

  • 41. Biomarkers of DHA status.
    Kuratko CN; Salem N
    Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):111-8. PubMed ID: 19545987
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immune cell membrane fatty acids and inflammatory marker, C-reactive protein, in patients with multiple sclerosis.
    Hon G; Hassan M; van Rensburg SJ; Abel S; Marais de W; van Jaarsveld P; Smuts C; Henning F; Erasmus R; Matsha T
    Br J Nutr; 2009 Nov; 102(9):1334-40. PubMed ID: 19454128
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of contemporary EEG derived depth of anesthesia monitors with a 5 step validation process.
    Heyse B; Van Ooteghem B; Wyler B; Struys MM; Herregods L; Vereecke H
    Acta Anaesthesiol Belg; 2009; 60(1):19-33. PubMed ID: 19459551
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An apoptosis biomarker for prediction of nonalcoholic steatohepatitis.
    Bantel H; Bahr MJ; Schulze-Osthoff K
    Hepatology; 2009 Sep; 50(3):991. PubMed ID: 19593820
    [No Abstract]   [Full Text] [Related]  

  • 45. Response to "The microEST in vitro test for embryotoxicity - a case of mistaken identity?" by Robert Combes.
    Schwengberg S; Bohlen H; Fronhoff B
    Toxicol In Vitro; 2009 Mar; 23(2):362-3. PubMed ID: 19111605
    [No Abstract]   [Full Text] [Related]  

  • 46. Improving stroke prognosis.
    Baird AE
    Neurology; 2009 Oct; 73(14):1084-5. PubMed ID: 19726749
    [No Abstract]   [Full Text] [Related]  

  • 47. AddNeuroMed--the European collaboration for the discovery of novel biomarkers for Alzheimer's disease.
    Lovestone S; Francis P; Kloszewska I; Mecocci P; Simmons A; Soininen H; Spenger C; Tsolaki M; Vellas B; Wahlund LO; Ward M;
    Ann N Y Acad Sci; 2009 Oct; 1180():36-46. PubMed ID: 19906259
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Anti-citrullinated peptide antibodies: novel markers for rheumatoid polyarthritis].
    Yalaoui S
    Arch Inst Pasteur Tunis; 2006; 83(1-4):13-7. PubMed ID: 19388592
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A biomarker concept for assessment of insulin resistance, beta-cell function and chronic systemic inflammation in type 2 diabetes mellitus.
    Pfützner A; Weber MM; Forst T
    Clin Lab; 2008; 54(11-12):485-90. PubMed ID: 19216254
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Laboratory issues in the implementation of the marker method.
    Cowan DA; Bartlett C
    Growth Horm IGF Res; 2009 Aug; 19(4):357-60. PubMed ID: 19574074
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synovial tissue sublining CD68 expression is a biomarker of therapeutic response in rheumatoid arthritis clinical trials: consistency across centers.
    Bresnihan B; Pontifex E; Thurlings RM; Vinkenoog M; El-Gabalawy H; Fearon U; Fitzgerald O; Gerlag DM; Rooney T; van de Sande MG; Veale D; Vos K; Tak PP
    J Rheumatol; 2009 Aug; 36(8):1800-2. PubMed ID: 19671815
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Let us know your thoughts on reproducibility.
    Lake F
    Biotechniques; 2019 Sep; 67(3):80. PubMed ID: 31387369
    [No Abstract]   [Full Text] [Related]  

  • 53. [Research of biomarker could develop biological monitoring].
    Jia G; Shen HQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Nov; 40(6):379-80. PubMed ID: 17313733
    [No Abstract]   [Full Text] [Related]  

  • 54. [About the ubiquity of the alpha coefficient in the validation studies].
    Dominguez-Lara SA
    Enferm Intensiva; 2016; 27(4):176. PubMed ID: 27496316
    [No Abstract]   [Full Text] [Related]  

  • 55. When do you need a validated assay?
    Booth B
    Bioanalysis; 2011 Dec; 3(24):2729-30. PubMed ID: 22185272
    [No Abstract]   [Full Text] [Related]  

  • 56. When I say... response process validity.
    Kreiter C
    Med Educ; 2015 Mar; 49(3):247-8. PubMed ID: 25693984
    [No Abstract]   [Full Text] [Related]  

  • 57. Systematic verification of bladder cancer-associated tissue protein biomarker candidates in clinical urine specimens.
    Tsai CH; Chen YT; Chang YH; Hsueh C; Liu CY; Chang YS; Chen CL; Yu JS
    Oncotarget; 2018 Jul; 9(56):30731-30747. PubMed ID: 30112103
    [TBL] [Abstract][Full Text] [Related]  

  • 58. COPD Exacerbation Biomarkers Validated Using Multiple Reaction Monitoring Mass Spectrometry.
    Leung JM; Chen V; Hollander Z; Dai D; Tebbutt SJ; Aaron SD; Vandemheen KL; Rennard SI; FitzGerald JM; Woodruff PG; Lazarus SC; Connett JE; Coxson HO; Miller B; Borchers C; McManus BM; Ng RT; Sin DD
    PLoS One; 2016; 11(8):e0161129. PubMed ID: 27525416
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of reverse phase protein microarrays for the validation of clusterin, a mid-abundant blood biomarker.
    Aguilar-Mahecha A; Cantin C; O'Connor-McCourt M; Nantel A; Basik M
    Proteome Sci; 2009 Apr; 7():15. PubMed ID: 19348683
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Would you prefer multiple reaction monitoring or antibodies with your biomarker validation?
    Issaq HJ; Veenstra TD
    Expert Rev Proteomics; 2008 Dec; 5(6):761-3. PubMed ID: 19086854
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.